Literature DB >> 24856421

Identification, epidemiological relatedness, and biofilm formation of clinical Chryseobacterium indologenes isolates from central Taiwan.

Yi-Cheng Chang1, Hsueh-Hsia Lo2, Hsiu-Ying Hsieh3, Shan-Min Chang4.   

Abstract

BACKGROUND: The clinical impact of Chryseobacterium indologenes infection is increasing; nevertheless, most studies had been conducted in northern Taiwan, but rarely in central Taiwan.
METHODS: Using 16S rRNA gene sequencing, 34 isolates of C. indologenes were identified at the Central Region Hospital Alliance between 2007 and 2011. Vitek 2 and matrix-assisted laser desorption ionization-time-of-flight mass spectrometry (MALDI-TOF MS) methods were compared for the feasibility to identify this bacterium. Drug susceptibility test, biofilm formation, and pulsed-field gel electrophoresis (PFGE) were also performed.
RESULTS: All isolates were collected from hospitalized patients with an average age of 70.8 ± 18.5 years. The most prevalent sample was urine (50.0%), followed by sputum (32.4%). The accuracy rate of species-level identification reached 94.1% using the Vitek 2 method and 85.3% using the MALDI-TOF MS method. All of the isolates were resistant to gentamicin, amikacin, ceftriaxone, chloramphenicol, colistin, and imipenem, but completely susceptible to minocycline. While analyzing biofilm-forming ability, 38.2% (13/34) of C. indologenes isolates displayed a positive phenotype using the Luria-Bertani (LB) medium. However, 80.0% (4/5) of invasive isolates were biofilm producers. Based on PFGE analysis, several clusters were found, and the possible intrahospital spread of this bacterium in this area could not be excluded.
CONCLUSION: Both Vitek 2 and MALDI-TOF MS methods showed good ability in the determination of C. indologenes. Among the examined drugs, minocycline was the most potent one. As many as 38.2% C. indologenes isolates showed biofilm-forming ability. PFGE analyses revealed the possible intrahospital transmission of this bacterium in central Taiwan.
Copyright © 2014. Published by Elsevier B.V.

Entities:  

Keywords:  Biofilm; Central Taiwan; Chryseobacterium indologenes; Epidemiological relatedness; Identification

Mesh:

Substances:

Year:  2014        PMID: 24856421     DOI: 10.1016/j.jmii.2014.04.004

Source DB:  PubMed          Journal:  J Microbiol Immunol Infect        ISSN: 1684-1182            Impact factor:   4.399


  10 in total

Review 1.  Chryseobacterium indologenes: an emerging infection in the USA.

Authors:  Ridhwi Mukerji; Radhika Kakarala; Susan Jane Smith; Halina G Kusz
Journal:  BMJ Case Rep       Date:  2016-04-06

2.  Differences in Clinical Manifestations, Antimicrobial Susceptibility Patterns, and Mutations of Fluoroquinolone Target Genes between Chryseobacterium gleum and Chryseobacterium indologenes.

Authors:  Jiun-Nong Lin; Chung-Hsu Lai; Chih-Hui Yang; Yi-Han Huang
Journal:  Antimicrob Agents Chemother       Date:  2019-04-25       Impact factor: 5.191

3.  Clinical and molecular characteristics of Chryseobacterium indologenes isolates at a teaching hospital in Shanghai, China.

Authors:  Yixin Zhang; Dan Li; Yang Yang; Jiachun Su; Xiaogang Xu; Minggui Wang; Yijian Chen; Ying Li
Journal:  Ann Transl Med       Date:  2021-04

4.  Chryseobacterium indologenes Keratitis: Successful Treatment of Multidrug-Resistant Strain.

Authors:  Ivan J Lee; Thomas Mauger
Journal:  Case Rep Ophthalmol Med       Date:  2021-05-11

5.  Whole genome sequencing uncovers a novel IND-16 metallo-β-lactamase from an extensively drug-resistant Chryseobacterium indologenes strain J31.

Authors:  Shaoqiang Wu; Beiwen Zheng; Tingting Wang; Xiawei Jiang; Chunyan Feng; Ang Li; Huihui Dong
Journal:  Gut Pathog       Date:  2016-10-21       Impact factor: 4.181

6.  First Isolation and Characterization of Chryseobacterium cucumeris SKNUCL01, Isolated from Diseased Pond loach (Misgurnus anguillicaudatus) in Korea.

Authors:  Sang Guen Kim; Sib Sankar Giri; Sang Wha Kim; Jun Kwon; Sung Bin Lee; Se Chang Park
Journal:  Pathogens       Date:  2020-05-21

7.  Pleural effusion due to Chryseobacterium indologenes: Case report and review of literature.

Authors:  Nazneen Arif; Swati Khullar; Ratnesh Kumar; Shiv Kumar Choudhary; Arti Kapil; Benu Dhawan
Journal:  J Lab Physicians       Date:  2019 Jul-Sep

8.  Chryseobacterium bacteraemia in a patient with heart failure: case report and literature review.

Authors:  Taylor Wood; Antonio Abbate; Inna Tchoukina; Michael P Stevens
Journal:  Eur Heart J Case Rep       Date:  2020-11-12

9.  Whole genome sequencing of the multidrug-resistant Chryseobacterium indologenes isolated from a patient in Brazil.

Authors:  Marcelo Silva Folhas Damas; Roumayne Lopes Ferreira; Emeline Boni Campanini; Gabriela Guerrera Soares; Leslie Camelo Campos; Pedro Mendes Laprega; Andrea Soares da Costa; Caio César de Melo Freire; André Pitondo-Silva; Louise Teixeira Cerdeira; Anderson Ferreira da Cunha; Maria-Cristina da Silva Pranchevicius
Journal:  Front Med (Lausanne)       Date:  2022-07-28

10.  Chryseobacterium indologenes Ventilator-Associated Pneumonia in an Elderly Patient: A Case Report.

Authors:  Mahdi M Fadlallah; Darine M Kharroubi; Zeinab Zeineddine; Sarah M Salman
Journal:  Cureus       Date:  2022-07-28
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.